Official announcement! Global biopharmaceutical giant Novo Nordisk joins hands with the internet chronic disease management giant FarStar Health (06086.HK) to use AI to reconstruct the value chain of blood sugar control and weight management, jointly building a new global benchmark for digital intelligence.

According to the Wise Wealth News APP, against the background of the in-depth implementation of the "Healthy China 2030" strategy and the vigorous promotion of the "Weight Management Year" policy, on July 18, "AI + Internet Medical" leading enterprise Ark Health (06086.HK) officially signed a strategic cooperation memorandum with the world's leading biopharmaceutical company Novo Nordisk.